EQS-News: MediClin AG: Disclosure of the preliminary figures of the 2022 financial year
EQS-News: MediClin AG
/ Key word(s): Preliminary Results
MediClin AG: Disclosure of the preliminary figures of the 2022 financial year
28.02.2023 / 14:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
Offenburg, 26 February 2023
Disclosure of the preliminary figures of the 2022 financial year
In the 2022 financial year MEDICLIN achieved Group sales in the amount of EUR 704.7 mill. (previous year: EUR 673.1 mill.) and a Group operating result of EUR 19.5 mill. (previous year: E§UR 11.6 mill.). As a result, both Group sales and Group operating result were within the corridor of the forecast published for the year 2022.
As far as Group operating result is concerned, higher sales revenues and lower depreciation and amortization of rights of use contributed to the improvement in earnings. The result was impacted by energy costs and one-off costs in connection with the closure of a post-acute care clinic.
Sales increase in the segments and the nursing care business area
In the post-acute (rehabilitation) segment, revenues of EUR 431.2 mill. were EUR 20.4 mill. or 5.0% above the comparative figure of the previous year. Sales of the acute segment of EUR 252.7 mill. increased by EUR 9.3 mill. or 3.8% compared to the previous year. Sales in the nursing care business area rose to EUR 18.7 mill. in the year under review (previous year: EUR 17.3 mill.).
As far as segment results are concerned, the post-acute segment achieved a result of EUR 21.2 mill. (previous year: EUR 15.3 million). With a loss of EUR 4.4 million, the acute segment was slightly above the previous year's figure (previous year: EUR -4.0 million).
Staff and investments
The number of employees was 9,959 on December 31, 2022. Calculated in full-time equivalents, the average number in the reporting year 2022 was 7,025 full-time employees (previous year: 7,115 full-time employees). In 2022, gross investments in fixed assets amounted to EUR 28.5 mill. (previous year: EUR 18.1 mill.).
The Annual Report 2022 will be available from 31 March 2023 under www.mediclin.de in German and English.
About MEDICLIN Aktiengesellschaft (Ticker: MED; WKN: 659 510)
MEDICLIN includes 35 clinics, seven care facilities and eleven medical care centers. The Group has around 8,300 beds/care places and employs around 10,000 people. In a strong network, MEDICLIN offers the patient integrative care from the first visit to the doctor through the operation and subsequent rehabilitation to outpatient aftercare. Doctors, therapists and nurses work together in a carefully coordinated manner. MEDICLIN designs the care and support of people in need of care according to their individual needs and personal needs.
MEDICLIN ─ a company of the Asklepios Group.
28.02.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com
|
Language: |
English |
Company: |
MediClin AG |
|
Okenstraße 27 |
|
77652 Offenburg |
|
Germany |
Phone: |
+49 (0)781 488-326 |
Fax: |
+49 (0)781 488-184 |
E-mail: |
[email protected] |
Internet: |
www.mediclin.de |
ISIN: |
DE0006595101 |
WKN: |
659510 |
Listed: |
Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: |
1570907 |
|
End of News |
EQS News Service |
1570907 28.02.2023 CET/CEST
Die wichtigsten Finanzdaten auf einen Blick
|
|
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Umsatzerlöse1 |
609,08 |
645,11 |
673,09 |
659,86 |
673,14 |
704,70 |
730,07 |
EBITDA1,2 |
27,01 |
37,35 |
93,58 |
77,50 |
85,22 |
90,92 |
98,73 |
EBITDA-Marge3 |
4,43 |
5,79 |
13,90 |
11,74 |
12,66 |
12,90 |
|
EBIT1,4 |
6,62 |
15,06 |
22,41 |
0,15 |
11,56 |
19,52 |
12,72 |
EBIT-Marge5 |
1,09 |
2,33 |
3,33 |
0,02 |
1,72 |
2,77 |
1,74 |
Jahresüberschuss1 |
3,96 |
7,76 |
9,68 |
-0,04 |
1,49 |
9,72 |
-10,72 |
Netto-Marge6 |
0,65 |
1,20 |
1,44 |
-0,01 |
0,22 |
1,38 |
-1,47 |
Cashflow1,7 |
19,34 |
29,77 |
69,59 |
118,69 |
81,97 |
34,64 |
78,00 |
Ergebnis je Aktie8 |
0,08 |
0,16 |
0,20 |
-0,19 |
0,03 |
0,20 |
-0,23 |
Dividende8 |
0,05 |
0,05 |
0,05 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen.
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: PricewaterhouseCoopers
|
INVESTOR-INFORMATIONEN |
©boersengefluester.de |
Mediclin |
WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
659510 |
2,600 |
Halten |
123,50 |
KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
10,00 |
19,19 |
0,52 |
19,55 |
KBV |
KCV |
KUV |
EV/EBITDA |
0,63 |
1,58 |
0,17 |
1,45 |
Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23 in % |
Hauptversammlung |
0,00 |
0,00 |
0,00 |
06.06.2024 |
Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
02.05.2025 |
31.07.2024 |
04.11.2024 |
28.03.2025 |
Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
7,08% |
1,48% |
-5,11% |
-1,52% |
|
|